首页> Antimicrobial agents and chemotherapy> Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.

Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.

导出 OA

翻译打印收藏纠错

第一作者： J B,Pain

第一单位： AP-HP, Clinical Pharmacology Department, Bichat Hospital, Paris, France.

作者： J B,Pain ^[1] ; M P,Lê ^[2] ; M,Caseris ^[3] ; C,Amiel ^[4] ; L,Lassel ^[5] ; C,Charpentier ^[6] ; A,Desnoyer ^[1] ; C,Farnoux ^[7] ; G,Pialoux ^[8] ; D,Descamps ^[6] ; G,Peytavin ^[9]

作者单位： AP-HP, Clinical Pharmacology Department, Bichat Hospital, Paris, France. ^[1] AP-HP, Clinical Pharmacology Department, Bichat Hospital, Paris, France minh.le@bch.aphp.fr. ^[2] AP-HP, General Pediatrics, Robert Debré Hospital, Paris, France. ^[3] AP-HP, Virology Department, Tenon Hospital, Paris, France AP-HP, UPMC Université Paris 06, UMRS CR7, Inserm U1135, Paris, France. ^[4] AP-HP, Infectious Diseases Unit, Tenon Hospital, Paris, France. ^[5] AP-HP, Virology Department, Bichat Hospital, Paris, France IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and UMR 1137, INSERM, Paris, France. ^[6] AP-HP, Neonatology Department, Robert Debré Hospital, Paris, France. ^[7] AP-HP, UPMC Université Paris 06, UMRS CR7, Inserm U1135, Paris, France. ^[8] AP-HP, Clinical Pharmacology Department, Bichat Hospital, Paris, France IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and UMR 1137, INSERM, Paris, France. ^[9]